Figure 1. TAK-448 structure (A) and effect on the hypothalamic-pituitary-gonadal axis (B). At the normal physiological state, GnRH pulses in the hypothalamus.

Slides:



Advertisements
Similar presentations
Effects of Repeated GnRH Agonist Administration in Normal Men Carrie Zimmer, M.D. PhD, Robert Rosenfield, M.D. University of Chicago-Pediatric Endocrinology.
Advertisements

Reproductive Hormones Gonads Source of sex hormones: androgens estrogens progestins produced in different proportions by both males and females.
GnRH Agonists Alter Body Composition After Long Term Exposure Grace Shearrer, (Brian S. Edwards, Arik W. Smith and Donal C. Skinner)
Follicle-Stimulating Hormone Induces Postmenopausal Dyslipidemia Through Inhibiting Hepatic Cholesterol Metabolism J Clin Endocrinol Metab 101: 254–263,
Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.
DB06719 Buserelin C62H90N16O15.
The timeline shows the day of menstrual cycle for a typical patient
Figure 2. Summary of trial events
ASSESMENT OF ENDOCRINE FUNCTIONS
Figure 3. The relationship between testosterone dose and mean serum total testosterone. Data are shown as mean serum total testosterone among measurements.
Figure 1. Twenty-four-hour plasma ACTH concentrations in insomniacs (▪) and controls (○). The thick black line indicates the sleep recording period. The.
Figure 1. A schematic representation of the stress system
Fig. 1. Schematic representation of ProCT and the other CT precursors (CTpr) derived from this prohormone (i.e. NProCT, CT-CCP-I, and CCP-I). The mean.
Fig. 1. Time line for investigations
Fig. 1. Kaplan-Meir survival curves for Stoke Cushing's patients, with follow-up duration in years on the x-axis. Number of patients in each subgroup is.
Fig. 1. Mean BMI and BMI Z-score (se) of the children with AA, TA, and TT genotypes in rs of the FTO gene. The P values are for the additive model.
Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.
Fig. 1. Study enrollment and disposition of participants
Figure 1. Illustrative 24-h serum LH concentration (IRMA) profiles and calculated LH secretory rates as determined by deconvolution analysis in one healthy.
Figure 1 The hypothalamic–pituitary–gonadal axis
Fig. 2. Plasma melatonin secretion profiles for each of the eight subjects across the three conditions in the study. Profiles are shown for the entire.
Figure 1 Plasma LH concentration (mean ± SEM) in llamas after IUI of PBS (n = 6) or seminal plasma (n = 6) or after mating with an urethrostomized (n =
B. Major regulatory effects of ovarian steroids on hypothalamic-pituitary function. Estrogen decreases the amount of follicle-stimulating hormone (FSH)
Fig. 1. Left, Total ghrelin; right, octanoylated ghrelin
Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447
Nat. Rev. Endocrinol. doi: /nrendo
Fig. 4. Single total plasma 8-isoprostane levels in both controls and type 2 diabetic patients. Diabetes Induces p66shc Gene Expression in Human Peripheral.
Figure 1. Circadian pattern of gastric pH in healthy control subjects documented before (P1) Ramadan, on the 10th day (P2) and on the 24th day (P3) of.
Figure 1. Consort flow diagram.
Fig. 1. Effect of bariatric surgery on BMI and plasma leptin concentration. BMI (A) and plasma leptin concentrations (B) were determined in 27 morbidly.
Fig. 1. Flow of subjects through different phases of the study.
Brian S. Edwards1, Cheryl S. Asa2, Donal C
Effects of chronic exposure to a high dose GnRH agonist (Deslorelin)
From: Low Vitamin D Status despite Abundant Sun Exposure
HT (n = 45), healthy control subjects (HC) (n = 22), DTC-I, recurrent or persistent DTC (n = 27), DTC-II, disease free DTC (n = 34). Tg clusters are defined.
Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty.
Copyright © 2015 by the American Osteopathic Association.
Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.
Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.
Fig. 5. Histopathological study of the tumor tissue removed from patient 2. A, Macroscopic view of a tumor slice showing a dense tissue occupying the center.
Figure 1. Analysis of four different hPRLR mRNA isoforms (L, I, S1a, and S1b) in human breast adipose tissue (Breast AT), sc abdominal.
Figure 1. Summary of PTH secretion from human parathyroid cells after caffeine treatment at concentrations of 0, 1, 10, and 50 μm at extracellular calcium.
Predicted values and SEs were based on linear mixed models
Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.
FIG. 1 Odds ratios (95% CIs) of metabolic syndrome and individual components calculated for clinical measures of periodontal disease (A and B). For gingival.
Reproductive Physiology Lecture 1 Hypothalamic-Pituitary-Gonadal axis
Figure 1. Serum concentrations of IGF-I (A), IGF-II (B), IGFBP-3 (C), and ALS (D) throughout life in GHD (closed circles) and healthy control (open circles)
From: Is Age a Risk Factor for Hypothyroidism in Pregnancy
Triangles and dotted lines are for mean values. , P <
Fig. 3. Plasma profiles of active GIP (A) and total GIP (B) concentrations after administration of single oral doses of sitagliptin 25 (white circles)
Fig. 6. Effect of Constitutively Active MEKK on JNK Activity αT3–1 cells were cotransfected with either N-terminally deleted, constitutively active MEKK1.
Figure 4. Inhibition of LPS-induced IL-1β and TNFα, but not IL-6, after exercise. Depicted are LPS-induced IL-1β (upper panel), IL-6 (middle panel), and.
Figure 1. Correlations between TNFα and HOMA IR in men (•) and women (○). Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population.
Figure 1. MRI study demonstrating the change in visceral and sc abdominal fat area in a typical pioglitazone-treated patient. Each picture shows a transverse.
Fig. 1. Serum levels of IGF-I vs
Colorado Agriscience Curriculum
Volume 54, Issue 4, Pages (October 2008)
FSH versus estrogen: Who's guilty of breaking bones?
Male contraception Fertility and Sterility
administration (single dose, 5 mg) in six healthy male volunteers.
therapy and to block androgen action
FSH versus estrogen: Who's guilty of breaking bones?
Nat. Rev. Endocrinol. doi: /nrendo
Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women  Ioannis E. Messinis, M.D., Ph.D.,
Zeev Shoham, M.D.  Fertility and Sterility 
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
Nat. Rev. Nephrol. doi: /nrneph
Figure 1. Randomization and dropouts.
Lanthanum pharmacokinetics: Are rat data misleading?
Dose-normalized plasma concentration-time curves of a mAb following subcutaneous (SC) and intravenous (IV) administration to cynomolgus monkeys (mean ±
Presentation transcript:

Figure 1. TAK-448 structure (A) and effect on the hypothalamic-pituitary-gonadal axis (B). At the normal physiological state, GnRH pulses in the hypothalamus lead to an elevation in T levels via stimulation of the pituitary. Continuous administration of TAK-448 suppresses GnRH pulses and T levels, primarily through the desensitization of the KISS1 receptor/GPR54. A low level of nonpulsatile GnRH leakage may be detected due to residual receptor activity (18). From: Sustained Exposure to the Investigational Kisspeptin Analog, TAK-448, Down-Regulates Testosterone into the Castration Range in Healthy Males and in Patients With Prostate Cancer: Results From Two Phase 1 Studies J Clin Endocrinol Metab. 2014;99(8):E1445-E1453. doi:10.1210/jc.2013-4236 J Clin Endocrinol Metab | Copyright © 2014 by the Endocrine Society

Figure 2. Part A: mean serum concentration-time profiles of total T (A), LH (B), and FSH (C) in healthy subjects receiving TAK-448 as a single-bolus dose (0.001–0.3 mg) or a 2-hour infusion (1–6 mg). From: Sustained Exposure to the Investigational Kisspeptin Analog, TAK-448, Down-Regulates Testosterone into the Castration Range in Healthy Males and in Patients With Prostate Cancer: Results From Two Phase 1 Studies J Clin Endocrinol Metab. 2014;99(8):E1445-E1453. doi:10.1210/jc.2013-4236 J Clin Endocrinol Metab | Copyright © 2014 by the Endocrine Society

Figure 3. Part B: mean serum concentrations of T (A), LH (B), and FSH (C) after TAK-448 administered as a single-bolus dose (d 1) and followed by a 13-day infusion (d 2–14) in healthy subjects. From: Sustained Exposure to the Investigational Kisspeptin Analog, TAK-448, Down-Regulates Testosterone into the Castration Range in Healthy Males and in Patients With Prostate Cancer: Results From Two Phase 1 Studies J Clin Endocrinol Metab. 2014;99(8):E1445-E1453. doi:10.1210/jc.2013-4236 J Clin Endocrinol Metab | Copyright © 2014 by the Endocrine Society

Figure 4. Patients with PC not receiving GnRH: aggregate individual serum T concentration-time curves after TAK-448 administration at 12 mg (A) and 24 mg (B). From: Sustained Exposure to the Investigational Kisspeptin Analog, TAK-448, Down-Regulates Testosterone into the Castration Range in Healthy Males and in Patients With Prostate Cancer: Results From Two Phase 1 Studies J Clin Endocrinol Metab. 2014;99(8):E1445-E1453. doi:10.1210/jc.2013-4236 J Clin Endocrinol Metab | Copyright © 2014 by the Endocrine Society

Figure 5. Mean plasma concentrations of TAK-448 up to 72 hours after the administration of a single-bolus dose in healthy subjects (part A of study; inset shows concentrations after 4 h) (A); and in healthy subjects during a 13-day sc infusion of TAK-448 (d 2–14), by treatment group (part B of study) (B). From: Sustained Exposure to the Investigational Kisspeptin Analog, TAK-448, Down-Regulates Testosterone into the Castration Range in Healthy Males and in Patients With Prostate Cancer: Results From Two Phase 1 Studies J Clin Endocrinol Metab. 2014;99(8):E1445-E1453. doi:10.1210/jc.2013-4236 J Clin Endocrinol Metab | Copyright © 2014 by the Endocrine Society